T8S-21942-67068
3 vaccinations
2 coded responses
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 662 / KS
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WHR-17320-79501
Child or adolescent in my care · Male · 2022-06-30
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Moderna
-
2021-01-16
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-18
-
2021-02-15
Dose 2 — Moderna
- 2021-08-16
-
2022-02-16
Survey response — 12 months, dose 2MedDRA: Cough, Dyspnoea, Fatigue, Rhinorrhoea — Feeling: GoodFree text: Runny nose, fatigue, cough, SOBMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2023-04-12
Survey response — 6 months, dose 3MedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2022-10-07 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 12 months, dose 2
Symptoms: Runny nose, fatigue, cough, SOB
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release